Utilization of Collaborative Practice Agreements between Physicians and Pharmacists as a Mechanism to Increase Capacity to Care for Hematopoietic Stem Cell Transplant Recipients

Julianna A. Merten, Jamie F. Shapiro, Alison M. Gulbis, Kamakshi V. Rao, Joseph Bubalo, Scott Lanum, Ashley Morris Engemann, Sepideh Shayani, Casey Williams, Helen Leather, Tracey Walsh-Chocolaad

    Research output: Contribution to journalReview article

    22 Scopus citations

    Abstract

    Survival after hematopoietic stem cell transplantation (HSCT) has improved and the number of allogeneic HSCTs performed annually in the United States is expected to reach 10,000 by 2015. The National Marrow Donor Program created the System Capacity Initiative to formulate mechanisms to care for the growing number of HSCT recipients. One proposed method to increase capacity is utilization of pharmacists to manage drug therapy via collaborative practice agreements (CPAs). Pharmacists have managed drug therapy in oncology patients with CPAs for decades; however, there are limited HSCT centers that employ this practice. Engaging in collaborative practice and billing agreements with credentialed pharmacists to manage therapeutic drug monitoring, chronic medical conditions, and supportive care in HSCT recipients may be cost-effective and enable physicians to spend more time on new or more complex patients. The goal of this paper is to provide a framework for implementation of a CPA and address how it may improve HSCT program capacity.

    Original languageEnglish (US)
    Pages (from-to)509-518
    Number of pages10
    JournalBiology of Blood and Marrow Transplantation
    Volume19
    Issue number4
    DOIs
    StatePublished - Apr 1 2013

    Keywords

    • Collaborative drug therapy management
    • Hematopoietic cell transplantation
    • Medication Therapy Management
    • National Marrow Donor Program
    • Pharmaceutical services
    • Physician capacity

    ASJC Scopus subject areas

    • Hematology
    • Transplantation

    Fingerprint Dive into the research topics of 'Utilization of Collaborative Practice Agreements between Physicians and Pharmacists as a Mechanism to Increase Capacity to Care for Hematopoietic Stem Cell Transplant Recipients'. Together they form a unique fingerprint.

  • Cite this

    Merten, J. A., Shapiro, J. F., Gulbis, A. M., Rao, K. V., Bubalo, J., Lanum, S., Engemann, A. M., Shayani, S., Williams, C., Leather, H., & Walsh-Chocolaad, T. (2013). Utilization of Collaborative Practice Agreements between Physicians and Pharmacists as a Mechanism to Increase Capacity to Care for Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation, 19(4), 509-518. https://doi.org/10.1016/j.bbmt.2012.12.022